68 related articles for article (PubMed ID: 19023053)
1. Systems biology. Cast of 1000 proteins shines in movies of cancer cells.
Kaiser J
Science; 2008 Nov; 322(5905):1176-7. PubMed ID: 19023053
[No Abstract] [Full Text] [Related]
2. Dynamic proteomics of individual cancer cells in response to a drug.
Cohen AA; Geva-Zatorsky N; Eden E; Frenkel-Morgenstern M; Issaeva I; Sigal A; Milo R; Cohen-Saidon C; Liron Y; Kam Z; Cohen L; Danon T; Perzov N; Alon U
Science; 2008 Dec; 322(5907):1511-6. PubMed ID: 19023046
[TBL] [Abstract][Full Text] [Related]
3. A tale of two tumor targets: topoisomerase I and tubulin. The Wall and Wani contribution to cancer chemotherapy.
Cragg GM; Newman DJ
J Nat Prod; 2004 Feb; 67(2):232-44. PubMed ID: 14987065
[TBL] [Abstract][Full Text] [Related]
4. Human DNA topoisomerase inhibitors from Potentilla argentea and their cytotoxic effect against MCF-7.
Tomczyk M; Drozdowska D; Bielawska A; Bielawski K; Gudej J
Pharmazie; 2008 May; 63(5):389-93. PubMed ID: 18557426
[TBL] [Abstract][Full Text] [Related]
5. Combined application of camptothecin and the guanylate cyclase activator YC-1: Impact on cell death and apoptosis-related proteins in ovarian carcinoma cell lines.
Lee SJ; Kim YJ; Lee CS; Bae J
Chem Biol Interact; 2009 Oct; 181(2):185-92. PubMed ID: 19481069
[TBL] [Abstract][Full Text] [Related]
6. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.
Siu FM; Che CM
J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of camptothecin.
Liu LF; Duann P; Lin CT; D'Arpa P; Wu J
Ann N Y Acad Sci; 1996 Dec; 803():44-9. PubMed ID: 8993499
[No Abstract] [Full Text] [Related]
8. Cell-surface expression of Hsp70 on hematopoietic cancer cells after inhibition of HDAC activity.
Jensen H; Andresen L; Hansen KA; Skov S
J Leukoc Biol; 2009 Oct; 86(4):923-32. PubMed ID: 19502564
[TBL] [Abstract][Full Text] [Related]
9. CKD-602, a camptothecin derivative, inhibits proliferation and induces apoptosis in glioma cell lines.
Kim YY; Park CK; Kim SK; Phi JH; Kim JH; Kim CY; Wang KC; Cho BK
Oncol Rep; 2009 Jun; 21(6):1413-9. PubMed ID: 19424618
[TBL] [Abstract][Full Text] [Related]
10. Relevance of extracellular and intracellular interactions of camptothecins as determinants of antitumor activity.
Beretta GL; Zunino F
Biochem Pharmacol; 2007 Nov; 74(10):1437-44. PubMed ID: 17540344
[TBL] [Abstract][Full Text] [Related]
11. Novel camptothecin derivatives as topoisomerase I inhibitors.
Basili S; Moro S
Expert Opin Ther Pat; 2009 May; 19(5):555-74. PubMed ID: 19441934
[TBL] [Abstract][Full Text] [Related]
12. Induction of oncogene addiction shift to NF-kappaB by camptothecin in solid tumor cells.
Togano T; Sasaki M; Watanabe M; Nakashima M; Tsuruo T; Umezawa K; Higashihara M; Watanabe T; Horie R
Biochem Biophys Res Commun; 2009 Dec; 390(1):60-4. PubMed ID: 19778522
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerase I and II inhibitory constituents from the bark of Tilia amurensis.
Choi JY; Seo CS; Zheng MS; Lee CS; Son JK
Arch Pharm Res; 2008 Nov; 31(11):1413-8. PubMed ID: 19023537
[TBL] [Abstract][Full Text] [Related]
14. HDAC2 mediates therapeutic resistance of pancreatic cancer cells via the BH3-only protein NOXA.
Fritsche P; Seidler B; Schüler S; Schnieke A; Göttlicher M; Schmid RM; Saur D; Schneider G
Gut; 2009 Oct; 58(10):1399-409. PubMed ID: 19528037
[TBL] [Abstract][Full Text] [Related]
15. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase.
Lau ST; Lin ZX; Liao Y; Zhao M; Cheng CH; Leung PS
Cancer Lett; 2009 Aug; 281(1):42-52. PubMed ID: 19286308
[TBL] [Abstract][Full Text] [Related]
16. Cellular profiling of small-molecule bioactivities: an alternative tool for chemical biology.
Berg T
Angew Chem Int Ed Engl; 2005 Aug; 44(32):5008-11. PubMed ID: 15973752
[No Abstract] [Full Text] [Related]
17. Terpyridine-platinum(II) complexes are effective inhibitors of mammalian topoisomerases and human thioredoxin reductase 1.
Lo YC; Ko TP; Su WC; Su TL; Wang AH
J Inorg Biochem; 2009 Jul; 103(7):1082-92. PubMed ID: 19525010
[TBL] [Abstract][Full Text] [Related]
18. Application of microfluidic gradient chip in the analysis of lung cancer chemotherapy resistance.
Siyan W; Feng Y; Lichuan Z; Jiarui W; Yingyan W; Li J; Bingcheng L; Qi W
J Pharm Biomed Anal; 2009 Apr; 49(3):806-10. PubMed ID: 19162424
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by scaffold modification.
You QD; Li ZY; Huang CH; Yang Q; Wang XJ; Guo QL; Chen XG; He XG; Li TK; Chern JW
J Med Chem; 2009 Sep; 52(18):5649-61. PubMed ID: 19715319
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological activities of topoisomerase I inhibitors, 6-arylmethylamino analogues of edotecarin.
Sunami S; Nishimura T; Nishimura I; Ito S; Arakawa H; Ohkubo M
J Med Chem; 2009 May; 52(10):3225-37. PubMed ID: 19397324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
